Soupy for Loopy is a GuideStar Exchange Gold Participant

The trial supported by the Soupy for Loopy Foundation will use bevacizumab (AvastinTM) and zoledronic acid (Zometa®) with low doses of the chemotherapeutic agent cyclophosphamide (cytoxan). Referred as N0702,

2008   $25,000

Funds will support NANT 2013-02 Phase I Study of Sorafenib with Cyclophosphamide and Topotecan in Patients with Relapsed and Refractory Neuroblastoma. 

Shop at AmazonSmile and Amazon will donate

to Soupy for Loopy

NANT Grants for Neuroblastoma Research

New Approaches to Neuroblastoma Therapy (NANT)

2014   $44,907